Machaon Diagnostics is a preferred laboratory partner to pharmaceutical firms conducting clinical trials in the areas of thrombosis, hemostasis, nephology and rare disease. We offer both CAP/CLIA and GLP testing and regulatory-compliant method validation solutions for submission to the FDA and other regulatory bodies. Machaon Diagnostics has emerged as a leading laboratory for complement gene sequencing and other testing, due to our rapid turnaround and expedited study capabilities. Machaon was founded in 2003.
Exsera BioLabs specializes in the field of complement, immune complex and anaphylactoid testing. Our Director is a recognized expert in the field having overseen countless studies and PI reports. Combine that with a team with decades of experience in complement testing, and Exsera BioLabs has the experience to understand your unique issues or complex results. We have a commitment to providing quality and timely results with the insight and expertise that makes a difference.
Quidel’s Specialty Products Group is focused on providing innovative research and diagnostic tools for identification of novel markers in autoimmune and Complement. Many of these products are unique in nature and provide researchers and clinicians valuable scientific and diagnostic information. Quidel offers products to meet biosafety testing and Complement dependent cytotoxicity testing requirements, such as normal human sera, proteins, monoclonal and polyclonal antibodies, depleted sera and Complement fragment ELISA assays.
Apellis’ approach is centered on the inhibition of the complement system, which is a cascade of interacting proteins and is an integral component of the immune system. We have developed our lead product candidates, which are analogs of the cyclic peptide compstatin, based on technology that we have exclusively licensed from the Trustees of the University of Pennsylvania… Read More